Focused on building reliable datasets, financial models, and research tools for value-minded investors. Committed to turning complex data into practical guidance for value-investing and long-term wealth.
Dr. Charlie Tian is the founder and CEO of GuruFocus.com, a leading global investment research platform established in 2004. With a Ph.D. in physics, Dr. Tian transitioned from science to finance, applying a data-driven, disciplined approach to value investing.
Medica SurB de CVMEX:MEDICAB -2.52%81 5-Year Yield-on-Cost % is 2.69 as of Aug. 02, 2026, which is 7% below its 10-year median of 2.88. GuruFocus rates MEX:MEDICAB with a GF Score™ of 81/100 and a GF Value™ of MXN46.76 (Modestly Overvalued). The stock has 5 warning signs investors should review. Among 275 Healthcare Providers & Services companies, Medica SurB de CV ranks worse than 53.09% on this metric.
Medica SurB de CV's yield on cost for the quarter that ended in Dec. 2025 was 2.69.
The historical rank and industry rank for Medica SurB de CV's 5-Year Yield-on-Cost % or its related term are showing as below:
MEX:MEDICAB'
s 5-Year Yield-on-Cost % Range Over the Past 10 Years
Min: 0.77 Med: 2.88 Max: 82.89
Current: 2.69
During the past 13 years, Medica SurB de CV's highest Yield on Cost was 82.89. The lowest was 0.77. And the median was 2.88.
MEX:MEDICAB's 5-Year Yield-on-Cost % is ranked worse than 53.09% of 275
companies
in the Healthcare Providers & Services industry
Industry Median: 2.99
vs MEX:MEDICAB: 2.69
Medica SurB de CV (MEX:MEDICAB) 5-Year Yield-on-Cost % Explanation
Of course the risk here is that the company may not raise its dividends as it did before. The key is to select the companies that can consistently raise its dividends. Usually companies with long history of raising dividends tend to do so.
Medica SurB de CV 5-Year Yield-on-Cost % Related Terms
MEX:MEDICAB vs HCA, THC, DVA: 5-Year Yield-on-Cost % Comparison
For the Medical Care Facilities subindustry, Medica SurB de CV's 5-Year Yield-on-Cost %, along with its competitors' market caps and 5-Year Yield-on-Cost % data, can be viewed below:
* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.
Medica SurB de CV 5-Year Yield-on-Cost % vs Healthcare Providers & Services Industry
For the Healthcare Providers & Services industry and Healthcare sector, Medica SurB de CV's 5-Year Yield-on-Cost % distribution charts can be found below:
* The bar in red indicates where Medica SurB de CV's 5-Year Yield-on-Cost % falls into.
Medica SurB de CV 5-Year Yield-on-Cost % Calculation
Dividend Yield % and dividend growth of a stock is an important factor for income investors. But if company A raises its dividend constantly faster than company B, company A's future dividend yield might be much higher than Company B's even if their yields are the same now and their stock prices do not change.
Yield on Cost assumes that you buy and the stock today, and hold it for 5 years. If the company raises it dividends at the same rate as it did over the past 5 years, the dividends investors receive annually in 5 years relative to the stock price today.
Medica SurB de CV (MEX:MEDICAB) has a 5-Year Yield-on-Cost % of 2.69 as of Aug. 02, 2026. 5-Year Yield on Cost measures the expected yield based on a company's current yield and 5-year dividend growth. View historical data on Medica SurB de CV and its competitors. This is near median its historical median of 2.88. Over the past decade, Medica SurB de CV's 5-Year Yield-on-Cost % has ranged from 0.77 to 82.89. According to the industry distribution chart, Medica SurB de CV ranks #146 out of 275 companies in the Healthcare Providers & Services industry, placing it in the top 53.1%.
Is Medica SurB de CV's 5-Year Yield-on-Cost % too high?
Medica SurB de CV's current 5-Year Yield-on-Cost % of 2.69 is near median its 10-year median of 2.88. Over the past 10 years, this metric has ranged from a low of 0.77 to a high of 82.89. The Healthcare Providers & Services industry median 5-Year Yield-on-Cost % is 2.99. Medica SurB de CV's value of 2.69 is 10% below this industry median. Based on the distribution chart, Medica SurB de CV ranks #146 out of 275 companies in the Healthcare Providers & Services industry, which is below the industry midpoint. Overall, Medica SurB de CV has a GF Score™ of 81/100 and is considered Modestly Overvalued, reflecting its overall financial health beyond just this single metric.
How does Medica SurB de CV's 5-Year Yield-on-Cost % compare to HCA and THC?
According to the Healthcare Providers & Services industry distribution chart, Medica SurB de CV ranks #146 out of 275 companies for 5-Year Yield-on-Cost %. This places Medica SurB de CV in the lower half of its industry. The industry median 5-Year Yield-on-Cost % is 2.99. Medica SurB de CV's value of 2.69 is 10% below this benchmark. Historically, Medica SurB de CV's own 5-Year Yield-on-Cost % has ranged from 0.77 to 82.89 over the past decade. While the company's 10-year median is 2.88 vs. the industry median of 2.99, Medica SurB de CV has consistently been below the industry average. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good 5-Year Yield-on-Cost % for a Healthcare Providers & Services company?
The median 5-Year Yield-on-Cost % among Healthcare Providers & Services companies is 2.99, based on 275 companies in the industry. Companies in the top quartile (top 25%) have a 5-Year Yield-on-Cost % significantly above this median, while those in the bottom quartile fall well below. However, 5-Year Yield-on-Cost % should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Medica SurB de CV's current 5-Year Yield-on-Cost % of 2.69 is 10% below the industry median. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high 5-Year Yield-on-Cost % mean?
A high 5-Year Yield-on-Cost % can signal that a stock is expensive relative to its fundamentals. 5-Year Yield on Cost measures the expected yield based on a company's current yield and 5-year dividend growth. View historical data on Medica SurB de CV and its competitors. For the Healthcare Providers & Services industry, the median 5-Year Yield-on-Cost % is 2.99 — values significantly above this may indicate overvaluation, while values below may suggest a bargain or underlying issues. Medica SurB de CV's current 5-Year Yield-on-Cost % is 2.69, which is near median its own 10-year median of 2.88. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Medica SurB de CV stock overvalued right now?
Based on GuruFocus' analysis, Medica SurB de CV (MEX:MEDICAB) is currently considered Modestly Overvalued. The stock's GF Value™ is MXN46.76, compared to a current price of MXN58.00 — trading 24% above its estimated fair value. The current 5-Year Yield-on-Cost % is 2.69, which is near median its 10-year median of 2.88 and 10% below the Healthcare Providers & Services industry median of 2.99. Medica SurB de CV's overall GF Score™ is 81/100 with 5 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is 5-Year Yield-on-Cost % calculated?
5-Year Yield-on-Cost % is calculated from a company's financial statements. For Medica SurB de CV (MEX:MEDICAB), the current 5-Year Yield-on-Cost % is 2.69 as of Aug. 02, 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.
Is Medica SurB de CV (MEX:MEDICAB) Overvalued in 2026?
Based on GuruFocus' analysis, Medica SurB de CV stock appears to be overvalued.
The current stock price of MXN58.00 is trading 24% above its estimated GF Value™ of MXN46.76.
GuruFocus considers Medica SurB de CV to be Modestly Overvalued.
Key valuation signals for MEX:MEDICAB:
5-Year Yield-on-Cost %: 2.69 (near median its 10-year median of 2.88)
GF Value™: MXN46.76 vs. price of MXN58.00 (24% above fair value)
Industry Position: 10% below the Healthcare Providers & Services median (#146 of 275)
No single metric tells the full story. See the MEX:MEDICAB stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.
Medica Sur SAB de CV is a medical care company specializes in emergency scenarios. The company offers emergency ambulance transportation, air transportation and paramedic assistance.
81GF Score
Get the complete analysis for MEX:MEDICAB
5-Year Yield-on-Cost % is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.
Quick Browse
Personalize
Premium Gurus 
Create New Portfolio
MEX:MEDICAB has been successfully added to your 
